Press Release: Rene Jaeggi Is Acknowledged by the Prestigious Ranks of Stanford Who’s Who
SINGAPORE, August 30, 2012 /Stanford Who’s Who/ — Stanford Who’s Who proudly announces the addition of Rene Jaeggi  to the premier ranks of professional individuals as a result of his work in the field of advanced biologics. As Managing Director of SABio Singapore Advanced Biologics Pte Ltd as well as throughout his entire career, Rene has routinely demonstrated the vision, diligence, and skills required to be considered among the best. SABio Singapore Advanced Biologics Pte Ltd started in 2010 as a response to the need of high quality biologics in the Singapore research community. Today, SABio holds a fully operational RNA oligonucleotide synthesis facility and is currently creating its antibody catalogue. Highly regarded as a reliable provider of custom made siRNAs and antibodies, the company has the technology and human resources to match and even exceed quality requirements. A man of many talents, Rene carries a proven track record as a scientist and manager while working with companies such as Skye Pharma, Vita Plant and the University of Basel. Rene is considered an authority in R&D of synthetic and natural drugs, bioassay test method development, lab technology and clinical trial support. He is an expert in operations and project management, and benefits from more than a decade of experience in the pharmaceutical industry. Endowed with a strategic vision, Rene also holds extensive experience in team management, new business development, project planning, technology management, relationship building, and client satisfaction. During his collegiate career, Rene earned a PhD in Biochemistry from James Cook University. In his free, he enjoys travelling the world. He is also passionate about music and enjoys reading science and nature journals and magazines. Use the following link to view more information on Rene Jaeggi  Browse the Stanford Who’s Who Social Media Branding website 
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.